William Wong

Oligomerix, Inc. develops novel therapeutics and diagnostic assays for alzheimer diseases. It is a biopharmaceutical company focused on the discovery and development of small molecule inhibitors, immunotherapeutic approaches and biomarkers targeting tau oligomers. The firm's platform is based on small neurotoxic aggregates of proteins such as tau oligomers, an important target for AD and other tauopathies characterized by the progressive accumulation of tau aggregates. The company was founded by James G. Moe, Eliot J. Davidowitz, Ishita Chatterjee and Pedro M. Rojas in 2006 and is headquartered in New York, NY.

Valera Pharmaceuticals, Inc. develops and commercializes products for the treatment of urology and endocrine conditions, diseases and disorders. The Company was founded in 1972 and is located in Cranbury, NJ.

Q-RNA, Inc. develops drugs for the treatment of Alzheimer's disease. The company was founded on August 30, 2002 and is headquartered in New York, NY.

Care Management Technologies, Inc. provides evidence-based behavioral health analytics and decision support tools. It offers data analytics, trend identification, predictive analyses and care tracking to support and enrich patient, provides monitoring functions that improve healthcare outcomes, support health home, lower costs and enhance patient engagement of care. The company was founded in 1999 and is headquartered in Morrisville, NC.

Treventis Corp. develops a small molecule drugs for Alzheimer's and other protein misfolding diseases. It developed a proprietary discovery platform, a high-resolution three-dimensional model of the common conformational region, enabling rational design of multiple lead compounds. The company was founded by Christopher J. Barden, Donald F. Weaver and Sultan Darvesh in 2008 and is headquartered in Toronto, Canada.

ShiftWise, Inc. provides healthcare-specific Software as a Service (SaaS) solutions that enables hospitals and staffing suppliers to quickly procure and manage contingent healthcare workers. The staff self-scheduling component of the ShiftWise solution improves the recruitment, retention and overall morale of the hospital’s internal staff. The company was founded by Jason Lander and Ross E. J. Barbieri in 2003 and is headquartered in Portland, OR.

Wheatley Medtech Partners LP invests in technology based private and public companies located in the United States. The fund targets companies operating in the fields of internet, software, IT consulting & telecommunications, banking & financial services, healthcare services and publishing & education. It provides financing for seed, early and later stage capital requirements. It makes co-investments.

Shire Regenerative Medicine, Inc. develops and commercializes living cell therapies. It manufactures and markets dermagraft, a bio-engineered skin substitute that assists in restoring damaged tissue and supports the body's natural healing process. The company was founded in 2004 and is headquartered in Westport, CT.

Wheatley Partners is a private equity firm founded in 1992 by Barry Fingerhut, Barry Rubenstein, Jonathan Lieber, Irwin Lieber. The firm is headquartered in New York.

Datascope Corp. manufactures and distributes surgical equipments. The company provides medical instruments such as intra aortic balloon pumps and catheters for use in cardiology, radiology, anesthesiology, cardiovascular, vascular surgery and emergency medicine. It also develops vascular grafts and patches for reconstructive blood vessel surgeries as well as multifunction patient monitoring devices. The company was founded in 1964 as New York Corp. It is headquartered in Montvale, NJ.

Redox Pharmaceutical Corp. develops and discovers metallo organic compounds for prophylactic and therapeutic uses. It serves the different applications such as antiviral, antibacterial and anti-inflammatory applications. The company was founded on April 16, 1984 and is headquartered in New York, NY.

The American Board of Internal Medicine operates as a self-appointed physician evaluation organization. The private company is based in Philadelphia, PA. The CEO of the company is Richard J. Baron.

Northwell Health, Inc. engages in the provision of medical and healthcare services. It offers several long-term care facilities, rehabilitation services, outpatient surgery centers, home care, hospice, diagnostic laboratory facilities, and emergency medical services. The company was founded in 1997 and is headquartered in New Hyde Park, NY.

Part of Northwell Health, Inc., The Feinstein Institutes for Medical Research operates as a medical research institute. The company is based in Manhasset, NY. The company was founded by David R. Dantzker. The CEO is Kevin J. Tracey.

Long Island Jewish Medical Center provides health care services. Its Schneider Children's Hospital gives treatment to kids it contains more than 150 beds and The Zucker Hillside Hospital, a psychiatric hospital that contains 220 beds. The company is headquartered in New Hyde Park, NY.

Visionsense Ltd. develops novel visualization solutions that bring natural stereoscopic sight to minimally invasive surgery (MIS). It delivers depth perception, 3D-HD resolution images and maneuvering flexibility through the smallest access diameters. The company was founded in 1998 and is headquartered in Petach Tikva. Israel.

Physicians for Human Rights (PHR) protects human health by protecting human rights. It fights to stop torture, disappearances and political killings and to improve hygiene conditions in prisons. The current projects of the company include the U.S. Campaign to Ban Landmines, Health Action AIDS Campaign, PHR Asylum Network, Health and Justice for Youth and Colleagues at Risk. The company was founded in 1986 by Jonathan Fine and is headquartered in New York, NY.

Origin Life Sciences, Inc. is a clinical-stage biotechnology company, which engages in the development of a plasma device that generate nitric oxide (NO) in the form of a plasma or NO stream. It focuses on its IonoJet platform, which provides therapeutic treatments which helps in immune system and blood vessel regulation, and tissue regeneration. The company was founded by Michael D. Preston and Alexander Dolgopolsky on June 14, 2010 and is headquartered in Princeton, NJ.